RxSight, Inc. Total Liabilities
RxSight, Inc. (RXST) had Total Liabilities of $89.36 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-05
- 2026-06-30: Liabilities $89.36M.
- 2026-03-31: Liabilities $36.70M.
- 2025-12-31: Liabilities $36.13M.
- 2025-09-30: Liabilities $32.56M.
| Period end | Liabilities |
|---|---|
| 2026-06-30 | $89.36M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $36.70M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $36.13M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $32.56M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $31.00M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $33.73M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $37.33M 10-K · filed 2026-02-25 |
| 2024-09-30 | $33.21M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $30.29M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $19.24M 10-Q · filed 2024-05-06 |
| 2023-12-31 | $22.19M 10-K · filed 2025-02-25 |
| 2023-09-30 | $20.37M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $38.07M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $57.52M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $60.26M 10-K · filed 2024-02-28 |
| 2022-09-30 | $59.75M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $56.73M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $53.90M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $54.48M 10-K · filed 2023-03-06 |
| 2021-09-30 | $52.84M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $54.98M 10-Q · filed 2021-09-09 |
| 2020-12-31 | $44.91M 10-K · filed 2022-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |